Search
Search Results
-
Les temps forts de Chicago 2017
The annual meeting of the American Society of Clinical Oncology (ASCO), the largest international oncology congress, which was held at Chicago on...
-
Carcinome hépatocellulaire : nouveaux concepts, nouvelles molécules et nouvelles approches
Recent biological knowledge on hepatocellular carcinoma (HCC) has underlined the complexity of this malignant disease. The crucial role of tumor...
-
Les remèdes à base de plantes médicinales dans le traitement du syndrome de l’intestin irritable (SII)
Irritable bowel syndrome (IBS) is a common ailment. Its average prevalence was estimated to 10%. It is a chronic relapsing disease that often eludes...
-
Risque de récidive locale en fonction de la classification moléculaire, exemple du cancer du sein
Local control is a major issue for cancer patients. Whatever the location of the primary tumor, local recurrence reveals the failure of local...
-
Colite induite par les inhibiteurs de checkpoint immunitaire : anticorps anti-CTLA-4 et anticorps anti-PD-1/PDL-1
The immune check point inhibitors, anti-CTLA-4 and anti-PD-1/PDL-1 antibodies are promising and involved in overall survival improvement....
-
Immunothérapie et dysfonctions thyroïdiennes : mise au point sur les connaissances actuelles
Immunotherapy is a revolution in the treatmant of melanoma, lung cancer, and some other cancers. Tolerance of these treatments is new. Among the...
-
Carcinome hépatocellulaire : quels soins de confort ?
Palliative care must be proposed early to hepatocellular carcinoma patients due to the alteration brought about by the disease in the quality of...
-
Les temps forts de l’ESMO 2016
This year, several studies presented at the ESMO congress may lead to changes in clinical practises. Firstly, immunotherapy may become the first-line...
-
Spécificités et recherches méthodologiques pour l’évaluation en soins de support en oncologie
Supportive care (pharmacological or non-pharmacological) has a key role in promoting holistic care of cancer patients. As such, the evaluation of the...
-
PPAC (programme personnalisé de l’après-cancer) : rationnel et mise en place
The growing number of breast cancer survivors challenges healthcare organizations, particularly oncology specialty and primary care providers....
-
Étude QUALIOR : faisabilité et efficacité d’un programme d’activité physique adaptée standardisée et encadrée à domicile chez des patients bénéficiant d’une thérapie ciblée orale pour un cancer métastatique
The adverse effect most commonly reported by patients treated with oral targeted therapies for advanced cancer is the onset of fatigue, which may be...
-
Place des antiangiogéniques dans le traitement des cancers du poumon
Management of lung cancers has evolved in recent years on many levels. These evolutions are illustrated by the identification of druggable molecular...